85
Participants
Start Date
March 15, 2021
Primary Completion Date
January 11, 2022
Study Completion Date
March 30, 2022
FX301
FX301 is an extended-release formulation of funapide being developed as a single injection peripheral nerve block for the management of acute postsurgical pain
Normal Saline
Single peripheral nerve injection
Lotus Clinical Research, Huntington Hospital, Pasadena
Lead Sponsor
Collaborators (1)
Lotus Clinical Research, LLC
OTHER
Pacira Pharmaceuticals, Inc
INDUSTRY